Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Gilead Sciences logo

Gilead Sciences Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Gilead Sciences holds $56.3B in total assets. Shareholders' equity is $23.5B against $22.2B in total debt. Cash and equivalents total $7.6B. The current ratio is 1.97 and debt-to-equity is 0.943. Based on the Q1 2026 filing.

Total Assets$56.3BTotal Stockholders Equity$23.5BLong Term Debt$20.9BCash And Equivalents$7.6BTotal Current Assets$18.6BTotal Current Liabilities$9.5B
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$156.28B
P/E Ratio16.96
ROE43.19%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$833M$737M$582M$808M$715M$645M
Accrued rebates$3.9B$4.2B$4.2B$4.9B$4.3B$4.1B
Other accrued liabilities$5.5B$4.6B$3.6B$3.8B$4B$3.4B
Current portion of long-term debt$1.8B$2.8B$2.8B$2.8B$2.8B$1.3B
Derivative Liabilities - Fair Value$3M$25M$7M$29M$40M$24M
Sales Discounts and Allowances$89M$90M$95M$97M$97M$98M
Total current liabilities$12B$12.3B$11.2B$12.3B$11.8B$9.5B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$5.3B$5.3B$5.6B$6B$5.9B$5.5B
Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)——$79M$19M—$15M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value——$519M—$724M$669M
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value——$519M—$724M$669M
Cash and cash equivalents$10B$7.9B$5.1B$7.3B$7.6B$7.6B
Finished goods$1.4B$1.5B$1.6B$1.7B$1.6B$1.7B
Short- term Investments$0—$69M$19M$68M$15M
Derivative Assets - Fair Value$128M$44M$7M$31M$56M$73M
Raw materials$1.3B$1.2B$1.3B$1.4B$1.4B$1.4B
Work in process$847M$1.1B$1B$1.3B$1.3B$1.3B
Inventories$1.9B$2B$2.1B$2.6B$2.6B$2.4B
Prepaid expenses and other current assets$3.1B$2.8B$2.9B$3.6B$4B$4.3B
Short-term investments$0—$69M$19M$68M$15M
Total current assets$19.2B$16.9B$14.7B$17.9B$18.3B$18.6B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$7.7B$8.1B$8.4B$8.7B$8.9B$9.3B
Accumulated other comprehensive income (loss)$132M$92M-$18M$36M$39M$78M
AOCI - Foreign Currency Translation Adjustment, Net of Tax$0$0$0$0$0$0
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March&#160;31, 2026 and December&#160;31, 2025, respectively$1M$1M$1M$1M$1M$1M
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding$0$0$0$0$0$0
Retained earnings$11.5B$10.9B$11.3B$12.8B$13.7B$14.1B
Total liabilities and stockholders' equity$59B$56.4B$55.7B$58.5B$59B$56.3B
Total stockholders' equity$19.3B$19.2B$19.7B$21.5B$22.7B$23.5B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Aggregate Notional Principal Outstanding$2.9B$3.4B$3.7B$3.3B$3.9B$3.6B
Cumulative Cost Basis$7.9B$8B$8.1B$8.2B$8.3B$8.4B
Less: allowances for chargebacks$759M$717M$696M$762M$843M$661M
Income taxes payable &#8211; long-term$830M$819M$859M$866M$896M$918M
Allowance for doubtful accounts$52M$59M$50M$41M$41M$44M
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax——$1M$0$1M$4M
Gross Unrealized Gains——$6M$10M$11M$1M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10——$7M$11M—$4M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10——$7M$11M—$4M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five——$1.9B$2B—$982M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five——$1.9B$2B—$979M
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One——$79M$19M—$15M
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One——$79M$19M—$15M
Common stock, par value (in dollars per share)$0.00$0.00$0.00$0.00$0.00$0.00
Common stock, shares authorized (in shares)5.6B5.6B5.6B5.6B5.6B5.6B
Common stock, shares issued (in shares)1.2B1.2B1.2B1.2B1.2B1.2B
Common Stock, Shares, Outstanding1.2B1.2B1.2B1.2B1.2B1.2B
Contract with Customer, Asset, after Allowance for Credit Loss$277M$304M$305M$695M$629M$589M
Contract with Customer, Liability$58M$56M$58M$56M$48M$47M
Short-term debt and current portion of long-term debt$1.8B$2.8B$2.8B$2.8B$2.8B$1.3B
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss$0—$2B$2B$3B$1B
Less than 12 months——$519M—$724M$669M
Estimated Fair Value——$2B$2B$3B$997M
Deferred income taxes$724M$709M$652M$597M$402M$392M
Derivative Asset, Subject to Master Netting Arrangement, after Offset and Deduction$125M—$0$2M$16M$49M
Potential reduction in net position of total derivative assets————$40M$24M
Derivative Liability, Subject to Master Netting Arrangement, after Offset and Deduction$0—$153M$63M$32M$6M
Potential reduction in net position of total derivative liabilities$3M$25M$7M$29M$40M$24M
Notional$2.9B$3.4B$3.7B$3.3B$3.9B$3.6B
Finite-Lived Intangible Assets, Accumulated Amortization$14.8B$15.4B$16B$16.6B$17.2B$17.8B
Gross Carrying Amount$31.9B$31.9B$31.9B$31.9B$31.9B$31.9B
Trademarks$2.9B$2.9B$2.7B$2.7B$2.3B$2.3B
Indefinite- lived intangible impairment$34.8B$34.8B$34.6B$34.6B$34.2B$34.2B
Inventory Net And Inventory Noncurrent$3.6B$3.8B$3.9B$4.4B$4.4B$4.3B
Estimated litigation liability$242M$220M$0$0$0$0
Noncontrolling interests in subsidiaries-$84M-$84M-$84M-$84M-$84M-$84M
Other long-term assets$386M$359M$369M$393M$393M$308M
Preferred Stock, Par or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Preferred Stock, Shares Authorized5M5M5M5M5M5M
Preferred Stock, Shares Outstanding000000
Severance accrual, current—$138M$92M$52M—$73M

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Deferred tax assets$724M$709M$652M$597M$402M$179M
Deferred Tax Assets and Other Non-Current Assets$3.8B$3.9B$4B$4.9B$4.8B$4.6B
Equity Securities (FV-NI and No Readily Determinable FV)$10.8B$8.1B$5.6B$8.3B$8.9B$8.8B
Goodwill$8.3B$8.3B$8.3B$8.3B$8.3B$8.3B
Indefinite-Lived Intangible Assets$2.9B$2.9B$2.7B$2.7B$2.3B$2.3B
Indefinite-Lived Intangible Assets, Gross$2.9B$2.9B$2.7B$2.7B$2.3B$2.3B
Indefinite-Lived Research and Development Assets$2.9B$2.9B$2.7B$2.7B$2.3B$2.3B
Indefinite-Lived Trademarks$2.9B$2.9B$2.7B$2.7B$2.3B$2.3B
Deferred tax assets$2.4B$2.6B$2.7B$2B$2B$1.8B
Intangible assets &#8212; net$17.1B$16.5B$15.9B$15.3B$14.7B$14.1B
Other intangible assets&#8212;net$19.9B$19.4B$18.6B$18B$17B$16.4B
Long- term Investments$0—$1.9B$2B$3B$983M
Other non-current assets$3.8B$3.9B$4B$4.9B$4.8B$4.6B
Property, plant and equipment at cost$7.9B$8B$8.1B$8.2B$8.3B$8.4B
Accumulated depreciation$2.5B$2.5B$2.6B$2.7B$2.7B$2.8B
Property and equipment, net$5.4B$5.4B$5.5B$5.5B$5.6B$5.6B
Software and Technology Licenses, Net$3.8B$3.9B$4B$4.9B$4.8B$4.6B
Total assets$59B$56.4B$55.7B$58.5B$59B$56.3B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Long-term debt$24.9B$22.1B$22.1B$22.1B$22.1B$20.9B
Other non-current liabilities$1.3B$1.3B$1.3B$1.2B$1.2B$1.2B